Search

Your search keyword '"Bettini R"' showing total 518 results
Start Over Author "Bettini R"
518 results on '"Bettini R"'

2. Use of Cone Beam Computed Tomography for identification and evaluation of medication-related osteonecrosis of the jaws: a dosimetric and multimodal imaging comparison

Author

Barillari, Marco, primary, Pardo, A., primary, Faccioni, P., primary, Guariglia, S., primary, Cavedon, C., primary, Zarantonello, M., primary, Melloni, F., primary, Zanutto, P., primary, Bettini, R., primary, Mansueto, G. C., primary, Zerman, N., primary, and Lonardi, F., primary

Published
2023
Full Text
View/download PDF

7. Preservation of Axillary Lymph Nodes Compared with Complete Dissection in T1-2 Breast Cancer Patients Presenting One or Two Metastatic Sentinel Lymph Nodes: The SINODAR-ONE Multicenter Randomized Clinical Trial

Author

Tinterri, C., Gentile, D., Gatzemeier, W., Sagona, A., Barbieri, E., Testori, A., Errico, V., Bottini, A., Marrazzo, E., Dani, C., Dozin, B., Boni, L., Bruzzi, P., Fernandes, B., Franceschini, D., Spoto, R., Torrisi, R., Scorsetti, M., Santoro, A., Canavese, G., Custodero, O., Troilo, V. L., Taffurelli, M., Cucchi, M. C., Galluzzo, V., Cabula, C., Cabula, R., Lazzaretti, M. G., Caruso, F., Castiglione, G., Grossi, S., Tavoletta, M. S., Rossi, C., Curcio, A., Friedman, D., Fregatti, P., Magni, C., Tazzioli, G., Papi, S., Giovanazzi, R., Chifu, C., Bettini, R., Pezzella, M., Michieletto, S., Saibene, T., Roncella, M., Ghilli, M., Sibilio, A., Cariello, A., Coiro, S., Falco, G., Meli, E. Z., Fortunato, L., Ciuffreda, L., Murgo, R., Battaglia, C., Rubino, L., Biglia, N., Bounous, V., Rovera, F. A., Chiappa, C., Pollini, G., Mirandola, S., Meneghini, G., and Di Bartolo, F.

Subjects
Sentinel Lymph Node Biopsy, Breast Neoplasms, Oncology, Lymphatic Metastasis, Axilla, Humans, Lymph Node Excision, Surgery, Female, Lymph Nodes, Prospective Studies, Neoplasm Recurrence, Local, Sentinel Lymph Node, Mastectomy
Abstract

The SINODAR-ONE trial is a prospective noninferiority multicenter randomized study aimed at assessing the role of axillary lymph node dissection (ALND) in patients undergoing either breast-conserving surgery or mastectomy for T1-2 breast cancer (BC) and presenting one or two macrometastatic sentinel lymph nodes (SLNs). The endpoints were to evaluate whether SLN biopsy (SLNB) only was associated with worsening of the prognosis compared with ALND in terms of overall survival (OS) and relapse.Patients were randomly assigned (1:1 ratio) to either removal of ≥ 10 axillary level I/II non-SLNs followed by adjuvant therapy (standard arm) or no further axillary treatment (experimental arm).The trial started in April 2015 and ceased in April 2020, involving 889 patients. Median follow-up was 34.0 months. There were eight deaths (ALND, 4; SNLB only, 4), with 5-year cumulative mortality of 5.8% and 2.1% in the standard and experimental arm, respectively (p = 0.984). There were 26 recurrences (ALND 11; SNLB only, 15), with 5-year cumulative incidence of recurrence of 6.9% and 3.3% in the standard and experimental arm, respectively (p = 0.444). Only one axillary lymph node recurrence was observed in each arm. The 5-year OS rates were 98.9% and 98.8%, in the ALND and SNLB-only arm, respectively (p = 0.936).The 3-year survival and relapse rates of T1-2 BC patients with one or two macrometastatic SLNs treated with SLNB only, and adjuvant therapy, were not inferior to those of patients treated with ALND. These results do not support the use of routine ALND.

Published
2022

15. Inhalable microparticles embedding calcium phosphate nanoparticles for heart targeting: The formulation experimental design

Author

Quarta, E. Sonvico, F. Bettini, R. De Luca, C. Dotti, A. Catalucci, D. Iafisco, M. Degli Esposti, L. Colombo, G. Trevisi, G. Rekkas, D.M. Rossi, A. Wong, T.W. Buttini, F. Colombo, P.

Abstract

Inhalation of Calcium Phosphate nanoparticles (CaPs) has recently unmasked the potential of this nanomedicine for a respiratory lung-to-heart drug delivery targeting the myocardial cells. In this work, we investigated the development of a novel highly respirable dry powder embedding crystalline CaPs. Mannitol was selected as water soluble matrix excipient for constructing respirable dry microparticles by spray drying technique. A Quality by Design approach was applied for understanding the effect of the feed composition and spraying feed rate on typical quality attributes of inhalation powders. The in vitro aerodynamic behaviour of powders was evaluated using a medium resistance device. The inner structure and morphology of generated microparticles were also studied. The 1:4 ratio of CaPs/mannitol led to the generation of hollow microparticles, with the best aerodynamic performance. After microparticle dissolution, the released nanoparticles kept their original size. © 2021 by the authors. Licensee MDPI, Basel, Switzerland.

Published
2021

21. Partial tablet coating by 3D printing

Author

Tsintavi, E. Rekkas, D.M. Bettini, R.

Abstract

In the last decade 3D printing (3DP) technology has gained increasing interest in the pharmaceutical field addressing several novel challenges such as on-demand manufacturing at the point of need, customization of drug release profiles and patient-specific solutions as well as combinations of several APIs in one dosage form. Therefore, 3DP can become a new and promising path to drug product development and manufacturing, able to support specific therapies and improve compliance, safety and effectiveness. The aim of this work was to partially coat tablets with a glyceride, namely Precirol ATO 5 using a semi-solids 3D printer as an approach for tuning the release of two Active Pharmaceutical Ingredients (APIs), the hydrophilic methyl-levodopa hydrochloride (Melevodopa) and the lipophilic Acyclovir. Various parameters of the 3DP coating process were purposefully modified using experimental design techniques in order to customize the selected APIs release profile, without affecting the core composition of the formulation. The percentage of the tablet surface coated, the number of coating layers as well as the coated sides of the tablet where the parameters which controlled the release profile for both APIs. Different dissolution profiles have been achieved by tuning these simple parameters, which revealed a non-Fickian release mechanism regardless of the API. © 2020 Elsevier B.V.

Published
2020

36. The Italian SurveY on carDiac rEhabilitation - 2008 (ISYDE-2008): a snapshot of current cardiac rehabilitation programmes and provides in Italy Part 2: ISYDE-2008 investigators and directory of italian cardiac rehabilitation centers

Author

Tramarin R., De Feo S., Ambrosetti M., Griffo R., Maslowsky F., Vaghi P., Riccio C., Carlon R., Castello A., Ferratini M., Schweiger C., Chieffo C., Diaco T., Ciglia C., Lapolla A., Pietropaolo F., Furgi G., Martin G., Semprini P., Avallone A., Bertoli D., Belardinelli R., Soffiantino F., Scrutinio D., Maxia P., Coco R., Giustarini C., Anniboletti P., Favretto G., Calisi P., Chiavetta C., Guarracini L., Marcellini G., Iannopollo M., Borrello G., Matta M., Peccerillo N., Boncompagni F., Amici A., Feraco E., Pulitano G., Tripodi E., Capomolla S., Golino P., Parrilli G., Di Patria A., Di Gioia C., Miceli D., Perrotta S., Rubino A., Aulitto V., Riccio G., Codec L., Coruzzi P., Violi E., Nardini M., Urbinati S., Dcruz S., Piepoli M., Fucili A., Cerulli M., Roberto B., Balestra G., Tuniz D., Gori P., Marini R., Morgera T., Di Mario F., Volterrani M., Galati A., Salustri A., Jesi A.P., Lacch A., Loperfido F., Corsiglia L., Pantaleo P., Gigli G., Marchesi D., Febo O., Cobelli F., Malinverni C., Jones N., Anzà C., Frizzelli R., Gei P., Acquistapace F., Carugo S., Malfatto G., Meloni C., Giordano A., Schizzarotto A., Zanettini R., Bosco R., Aglieri S., Caprioli G., Cuocina N., Salvetti S., Savonelli C., Corda G., Meinecke C., Castiglioni, Pierfranco R., Giani P., Robustelli F., Gullace G., Passoni F., Barelli M.V., Richichi I., Rossi A., Politi, Persico M., Alessandrini F., Giannuzzi P., Mazzucco G., Bosimini E., Riva G., Massobrio N., Gondoni L., Aina F., Ingignoli B., Cal M.V., Carpagnano A., Costante A., Villella M., La Rosa C., Sannia L., Barbanto P., Rametta R., Albanese D., Circo A., Raciti R., Scarnato L., Dispensa F., La Spina L., Stuto A., Vasco C., Gibiino S., Gabriele M., Dispensieri C., Carini V., Provvidenza M., Scalzini A., Macchi C., Vannucci M., Iacopetti L., Cordoni M., Gabriele F., Pitscheider W., Bettini R., Girardini D., Mandorla S., Anniboletti F., Patriarchi F., Baroni P.L., Bordin F., Biondi P., Bellotto F., Zanocco A., Ponchia A., Mantovani E., Li Greci E., Celegon L., Baracchi S., Pizzolato G., Peroni L., Apolloni E., Guarniero M., Roncon L., VIGORITO, CARLO, Tramarin, R., De Feo, S., Ambrosetti, M., Griffo, R., Maslowsky, F., Vaghi, P., Riccio, C., Carlon, R., Castello, A., Ferratini, M., Schweiger, C., Chieffo, C., Vigorito, Carlo, Diaco, T., Ciglia, C., Lapolla, A., Pietropaolo, F., Furgi, G., Martin, G., Semprini, P., Avallone, A., Bertoli, D., Belardinelli, R., Soffiantino, F., Scrutinio, D., Maxia, P., Coco, R., Giustarini, C., Anniboletti, P., Favretto, G., Calisi, P., Chiavetta, C., Guarracini, L., Marcellini, G., Iannopollo, M., Borrello, G., Matta, M., Peccerillo, N., Boncompagni, F., Amici, A., Feraco, E., Pulitano, G., Tripodi, E., Capomolla, S., Golino, P., Parrilli, G., Di Patria, A., Di Gioia, C., Miceli, D., Perrotta, S., Rubino, A., Aulitto, V., Riccio, G., Codec, L., Coruzzi, P., Violi, E., Nardini, M., Urbinati, S., Dcruz, S., Piepoli, M., Fucili, A., Cerulli, M., Roberto, B., Balestra, G., Tuniz, D., Gori, P., Marini, R., Morgera, T., Di Mario, F., Volterrani, M., Galati, A., Salustri, A., Jesi, A. P., Lacch, A., Loperfido, F., Corsiglia, L., Pantaleo, P., Gigli, G., Marchesi, D., Febo, O., Cobelli, F., Malinverni, C., Jones, N., Anzà, C., Frizzelli, R., Gei, P., Acquistapace, F., Carugo, S., Malfatto, G., Meloni, C., Giordano, A., Schizzarotto, A., Zanettini, R., Bosco, R., Aglieri, S., Caprioli, G., Cuocina, N., Salvetti, S., Savonelli, C., Corda, G., Meinecke, C., Castiglioni, Pierfranco, R., Giani, P., Robustelli, F., Gullace, G., Passoni, F., Barelli, M. V., Richichi, I., Rossi, A., Politi, Persico, M., Alessandrini, F., Giannuzzi, P., Mazzucco, G., Bosimini, E., Riva, G., Massobrio, N., Gondoni, L., Aina, F., Ingignoli, B., Cal, M. V., Carpagnano, A., Costante, A., Villella, M., La Rosa, C., Sannia, L., Barbanto, P., Rametta, R., Albanese, D., Circo, A., Raciti, R., Scarnato, L., Dispensa, F., La Spina, L., Stuto, A., Vasco, C., Gibiino, S., Gabriele, M., Dispensieri, C., Carini, V., Provvidenza, M., Scalzini, A., Macchi, C., Vannucci, M., Iacopetti, L., Cordoni, M., Gabriele, F., Pitscheider, W., Bettini, R., Girardini, D., Mandorla, S., Anniboletti, F., Patriarchi, F., Baroni, P. L., Bordin, F., Biondi, P., Bellotto, F., Zanocco, A., Ponchia, A., Mantovani, E., Li Greci, E., Celegon, L., Baracchi, S., Pizzolato, G., Peroni, L., Apolloni, E., Guarniero, M., and Roncon, L.

Subjects
Pulmonary and Respiratory Medicine, Studio ISYDE, medicine.medical_specialty, Time Factors, Cardiologia Riabilitativa, medicine.medical_treatment, lcsh:Medicine, Directory, Rehabilitation Centers, Risk profile, medicine, Directories as Topic, Internet, Cardiac Rehabilitation, Rehabilitation, business.industry, Core component, Prevenzione Secondaria, lcsh:R, Health Surveys, Government Programs, Italy, Cardiovascular Diseases, Physical therapy, Snapshot (computer storage), Cardiology and Cardiovascular Medicine, business
Abstract

From January 28th to February 10th, 2008 the Italian Society of Cardiac Rehabilitation and Prevention (GICR) conducted a national web-based survey aimed to provide specific and updated information on organization and core components of cardiac rehabilitation (CR) in Italy, and to describe, both in residential and out-patient settings, indications for CR, clinical characteristics of referred patients, risk profile, performed diagnostic procedures, exercise and educational programme, treatments and arrangements for the follow-up [1, 2]. The ISYDE-2008 is a multicenter, longitudinal, prospective observation study whose design was previously described [1, 2].

Published
2016
Full Text
View/download PDF

39. Nebulized coenzyme Q10 nanosuspensions: A versatile approach for pulmonary antioxidant therapy

Author

Rossi, I, Sonvico, F, McConville, JT, Rossi, F, Fröhlich, E, Zellnitz, S, Rossi, A, Del Favero, E, Bettini, R, and Buttini, F

Subjects
Aerosols, Ubiquinone, Cell Survival, Surface Properties, Viscosity, Nebulizers and Vaporizers, Chemistry, Pharmaceutical, Biological Transport, Antioxidants, Drug Liberation, Drug Delivery Systems, Drug Stability, A549 Cells, Stearates, Calibration, Lecithins, Humans, Vitamin E, Nanoparticles, Pharmacology & Pharmacy, Particle Size, Lung
Abstract

© 2017 Elsevier B.V. Coenzyme Q10 (CoQ10) is an antioxidant substance indicated as a dietary supplement which has been proposed as adjuvant in the treatment of cardiovascular disorders and cancer for its protective and immunostimulating activities. The aim of this work was the production by high-pressure homogenization, characterization and stability investigation of three different CoQ10 nanosuspensions designed to be administered to the lungs by nebulization. Three surfactants, i.e. lecithin, PEG32 stearate and vitamin-E TPGS, were selected to stabilize CoQ10 formulations. Preparations were identified as nanosuspensions (particle size in the range 35–60 nm): the smallest particles were obtained with vitamin-E TPGS and denoted a core-shell structure. The CoQ10 delivered from a commercial air-jet nebulizer was in all the cases around 30% of the loaded dose. The nanosuspension containing PEG32 stearate presented the highest respirable fraction (70.6%) and smallest MMAD (3.02 μm). Stability tests showed that the most stable formulation, after 90 days, was the one containing vitamin-E TPGS, followed by the CoQ10-lecithin formulation. Interestingly, those formulations were demonstrated to be suitable also for nebulizers using other mechanisms of aerosol production such as ultrasound and vibrating mesh nebulizers. Studies focused on in vitro cellular toxicity of the formulations and their single components using A549 human lung cells showed no obvious cytotoxicity for the formulations containing lecithin and PEG 32 stearate. Vitamin-E TPGS alone was shown to be able to damage the plasma membrane, nevertheless, cell damage was decreased when vitamin-E TPGS was present in the formulation with CoQ10.

Published
2017

40. Italian Cardiological Guidelines for Sports Eligibility in Athletes with Heart Disease

Author

Biffi, A, Delise, P, Zeppilli, P, Giada, F, Pelliccia, A, Penco, Maria, Casasco, M, Colonna, P, D'Andrea, A, D'Andrea, L, Gazale, G, Inama, G, Spataro, A, Villella, A, Marino, P, Pirelli, S, Romano, V, Cristiano, A, Bettini, R, Thiene, G, Furlanello, F, Corrado, D, Italian Society of Sports Cardiology, and Italian Sports Medicine Federation

Subjects
medicine.medical_specialty, Applied physiology, Heart disease, Sports medicine, business.industry, MEDLINE, General Medicine, Disease, medicine.disease, athletes, Settore M-EDF/01 - METODI E DIDATTICHE DELLE ATTIVITÀ MOTORIE, Family medicine, English version, Medicine, Eligibility Determination, Cardiology and Cardiovascular Medicine, business, Ischemic heart, cardiological guidelines
Abstract

In Italy the existence of a law on health protection of competitive sports since 1982 has favored the creation and the revision of these cardiological guidelines (called COCIS), which have reached their fourth edition (1989-2009). The present article is the second English version, which has summarized the larger version in Italian. The experience of the experts consulted in the course of these past 20 years has facilitated the application and the compatibility of issues related to clinical cardiology to the sports medicine field. Such prolonged experience has allowed the clinical cardiologist to acquire knowledge of the applied physiology of exercise and, on the other hand, has improved the ability of sports physicians in cardiological diagnostics. All this work has produced these guidelines related to the judgment of eligibility for competitive sports in the individual clinical situations and in the different cardiovascular abnormalities and/or heart disease. Numerous arguments are debated, such as interpretation of the athlete's ECG, the utility of a preparticipation screening, arrhythmias, congenital heart disease, cardiomyopathies, arterial hypertension, ischemic heart disease and other particular issues.

Published
2013
Full Text
View/download PDF

41. Multi-kinetics and site-specific release of gabapentin and flurbiprofen from oral fixed-dose combination: in vitro release and in vivo food effect

Author

Sonvico, F, Conti, C, Colombo, G, Buttini, F, Colombo, P, Bettini, R, Barchielli, M, Leoni, B, Loprete, L, Rossi, A, Sonvico, F, Conti, C, Colombo, G, Buttini, F, Colombo, P, Bettini, R, Barchielli, M, Leoni, B, Loprete, L, and Rossi, A

Abstract

© 2017 Elsevier B.V. In this work, a fixed-dose combination of gabapentin and flurbiprofen formulated as multilayer tablets has been designed, developed and studied in vitro and in vivo. The aim was to construct a single dosage form of the two drugs, able to perform a therapeutic program involving three release kinetics and two delivery sites, i.e., immediate release of gabapentin, intra-gastric prolonged release of gabapentin and intestinal (delayed) release of flurbiprofen. An oblong three-layer tablet was manufactured having as top layer a floating hydrophilic polymeric matrix for gastric release of gabapentin, as middle layer a disintegrating formulation for immediate release of a gabapentin loading dose and as bottom layer, an uncoated hydrophilic polymeric matrix, swellable but insoluble in gastric fluids, for delayed and prolonged release of flurbiprofen in intestinal environment. The formulations were studied in vitro and in vivo in healthy volunteers. The in vitro release rate assessment confirmed the programmed delivery design. A significant higher bioavailability of gabapentin administered 30 min after meal, compared to fasting conditions or to dose administration 10 min before meal, argued in favor of the gastro-retention of gabapentin prolonged release layer. The two drugs were delivered at different anatomical sites, since the food presence prolonged the gastric absorption of gabapentin from the floating layer and delayed the flurbiprofen absorption. The attainment of a successful delayed release of flurbiprofen was realized by a matrix based on a polymers' combination. The combined use of three hydrophilic polymers with different pH sensitivity provided the dosage form layer containing flurbiprofen with gastro-resistant characteristics without the use of film coating.

Published
2017

42. Spray-dried amikacin sulphate powder for inhalation in cystic fibrosis patients: The role of ethanol in particle formation

Author

Belotti, S. Rossi, A. Colombo, P. Bettini, R. Rekkas, D. Politis, S. Colombo, G. Balducci, A.G. Buttini, F.

Abstract

A Central Composite Design (CCD) was applied in order to identify positive combinations of the production parameters of amikacin sulphate spray-dried powders for inhalation, with the intent to expand the experimental space defined in a previous half-fractional factorial design. Three factors, namely drying temperature, feed rate and ethanol proportion, have been selected out of the initial five. In addition, the levels of these factors were increased from two to three and their effect on amikacin respirability was evaluated. In particular, focus was given on the role of ethanol presence on the formation of the microparticles for inhalation. The overall outcome of the CCD was that amikacin respirability was not substantially improved, as the optimum region coincided with areas already explored with the fractional factorial design. However, expanding the design space towards smaller ethanol levels, including its complete absence, revealed the crucial role of this solvent on the morphology of the produced particles. Peclet number and drug solubility in the spraying solution helped to understand the formation mechanism of these amikacin sulphate spray-dried particles. © 2015 Elsevier B.V. All rights reserved.

Published
2015

44. Cardiac rehabilitation in very old patients: data from the Italian Survey onCardiac Rehabilitation-2008 (ISYDE-2008)--official report of the ItalianAssociation for Cardiovascular Prevention, Rehabilitation, and Epidemiology

Author

GIALLAURIA, FRANCESCO, VIGORITO, CARLO, Tramarin R, Fattirolli F, Ambrosetti M, De Feo S, Griffo R, Riccio C, Piepoli M, Guarracini L, Ciglia C, Marcellini G, Iannopollo M, Borrello G, Matta M, Peccerillo N, Boncompagni F, Amici A, Pietropaolo F, Feraco E, Pulitano G, Tripodi E, Furgi G, Chieffo C, Capomolla S, Golino P, Parrilli G, Di Patria A, Di Gioia C, Micieli D, Vigorito C, Perrotta S, Rubino A, Aulitto V, Riccio G, Codec L, Coruzzi P, Violi E, Nardini M, Urbinati S, Dcruz S, Semprini P, Fucili A, Cerulli M, Roberto B, Balestra G, Tuniz D, Martin G, Gori P, Marini R, Morgera T, Di Mario F, Volterrani M, Galati A, Salustri A, Jesi AP, Lacch A, Loperfido F, Corsiglia L, Pantaleo P, Gigli G, Bertoli D, Marchesi D, Febo O, Cobelli F, Malinverni C, Ferratini M, Jones N, Anzà C, Frizzelli R, Gei P, Acquistapace F, Pedretti R, Carugo S, Malfatto G, Diaco T, Meloni C, Giordano A, Schizzarotto A, Zanettini R, Bosco R, Aglieri S, Caprioli G, Cuocina N, Lazzaroni L, Lorenzi A, Savonelli C, Veniani M, Corda G, Meinecke C, Castiglioni G, Pierfranco R, Giani P, Robustelli della Cuna F, Gullace G, Passoni F, Barelli MV, Richichi I, Rossi A, Politi A, Belardinelli R, Persico M, Giannuzzi P, Mazzucco G, Bosimini E, Riva G, Soffiantino F, Massobrio N, Gondoni L, Aina F, Ingignoli B, Cal MV, Costante A, Scrutinio D, Villella M, La Rosa C, Sannia L, Barbanto P, Castello A, Coco R, Rametta R, Albanese D, Circo A, Raciti R, Scarnato L, Dispensa F, La Spina L, Stuto A, Vasco C, Gibiino S, Gabriele M, Dispensieri C, Carini V, Provvidenza M, Scalzini A, Giustarini C, Macchi C, Vannucci M, Iacopetti L, Cordoni M, Gabriele F, Santoni R, Pitscheider W, Bettini R, Girardini D, Mandorla S, Anniboletti F, Patriarchi F, Favretto G, Baroni PL, Bordin F, Biondi P, Bellotto F, Zanocco A, Ponchia A, Mantovani E, Li Greci E, Carlon R, Celegon L, Baracchi S, Pizzolato G, Peroni L, Apolloni E, Mosele G, Guarnerio M., Giallauria, Francesco, Vigorito, Carlo, Tramarin, R, Fattirolli, F, Ambrosetti, M, De Feo, S, Griffo, R, Riccio, C, Piepoli, M, Guarracini, L, Ciglia, C, Marcellini, G, Iannopollo, M, Borrello, G, Matta, M, Peccerillo, N, Boncompagni, F, Amici, A, Pietropaolo, F, Feraco, E, Pulitano, G, Tripodi, E, Furgi, G, Chieffo, C, Capomolla, S, Golino, P, Parrilli, G, Di Patria, A, Di Gioia, C, Micieli, D, Vigorito, C, Perrotta, S, Rubino, A, Aulitto, V, Riccio, G, Codec, L, Coruzzi, P, Violi, E, Nardini, M, Urbinati, S, Dcruz, S, Semprini, P, Fucili, A, Cerulli, M, Roberto, B, Balestra, G, Tuniz, D, Martin, G, Gori, P, Marini, R, Morgera, T, Di Mario, F, Volterrani, M, Galati, A, Salustri, A, Jesi, Ap, Lacch, A, Loperfido, F, Corsiglia, L, Pantaleo, P, Gigli, G, Bertoli, D, Marchesi, D, Febo, O, Cobelli, F, Malinverni, C, Ferratini, M, Jones, N, Anzà, C, Frizzelli, R, Gei, P, Acquistapace, F, Pedretti, R, Carugo, S, Malfatto, G, Diaco, T, Meloni, C, Giordano, A, Schizzarotto, A, Zanettini, R, Bosco, R, Aglieri, S, Caprioli, G, Cuocina, N, Lazzaroni, L, Lorenzi, A, Savonelli, C, Veniani, M, Corda, G, Meinecke, C, Castiglioni, G, Pierfranco, R, Giani, P, Robustelli della Cuna, F, Gullace, G, Passoni, F, Barelli, Mv, Richichi, I, Rossi, A, Politi, A, Belardinelli, R, Persico, M, Giannuzzi, P, Mazzucco, G, Bosimini, E, Riva, G, Soffiantino, F, Massobrio, N, Gondoni, L, Aina, F, Ingignoli, B, Cal, Mv, Costante, A, Scrutinio, D, Villella, M, La Rosa, C, Sannia, L, Barbanto, P, Castello, A, Coco, R, Rametta, R, Albanese, D, Circo, A, Raciti, R, Scarnato, L, Dispensa, F, La Spina, L, Stuto, A, Vasco, C, Gibiino, S, Gabriele, M, Dispensieri, C, Carini, V, Provvidenza, M, Scalzini, A, Giustarini, C, Macchi, C, Vannucci, M, Iacopetti, L, Cordoni, M, Gabriele, F, Santoni, R, Pitscheider, W, Bettini, R, Girardini, D, Mandorla, S, Anniboletti, F, Patriarchi, F, Favretto, G, Baroni, Pl, Bordin, F, Biondi, P, Bellotto, F, Zanocco, A, Ponchia, A, Mantovani, E, Li Greci, E, Carlon, R, Celegon, L, Baracchi, S, Pizzolato, G, Peroni, L, Apolloni, E, Mosele, G, and Guarnerio, M.

Subjects
cardiac rehabilitation, trial, ISYDE
Abstract

BACKGROUND: Using data from the Italian SurveY on carDiac rEhabilitation-2008 (ISYDE-2008), this study provides insight into the level of implementation of cardiac rehabilitation (CR) in very old cardiac patients. METHODS: Data from 165 CR units were collected online from January 28 to February 10, 2008. RESULTS: The study cohort consisted of 2,281 patients (66.9 ± 11.8 years): 1,714 (62.4 ± 9.6 years, 78% male) aged

Published
2010

45. Spray dried amikacin powder for inhalation in cystic fibrosis patients: A quality by design approach for product construction

Author

Belotti, S. Rossi, A. Colombo, P. Bettini, R. Rekkas, D. Politis, S. Colombo, G. Balducci, A.G. Buttini, F.

Abstract

An amikacin product for convenient and compliant inhalation in cystic fibrosis patients was constructed by spray-drying in order to produce powders of pure drug having high respirability and flowability. An experimental design was applied as a statistical tool for the characterization of amikacin spray drying process, through the establishment of mathematical relationships between six Critical Quality Attributes (CQAs) of the finished product and five Critical Process Parameters (CPPs). The surface-active excipient, PEG-32 stearate, studied for particle engineering, in general did not benefit the CQAs of the spray dried powders for inhalation. The spray drying feed solution required the inclusion of 10% (v/v) ethanol in order to reach the desired aerodynamic performance of powders. All desirable function solutions indicated that the favourable concentration of amikacin in the feed solution had to be kept at 1% w/v level. It was found that when the feed rate of the sprayed solution was raised, an increase in the drying temperature to the maximum value (160 °C) was required to maintain good powder respirability. Finally, the increase in drying temperature always led to an evident increase in emitted dose (ED) without affecting the desirable fine particle dose (FPD) values. The application of the experimental design enabled us to obtain amikacin powders with both ED and FPD, well above the regulatory and scientific references. The finished product contained only the active ingredient, which keeps low the mass to inhale for dose requirement. © 2014 Elsevier B.V.

Published
2014

47. The Italian SurveY on carDiac rEhabilitation 2008 (ISYDE 2008): study presentation

Author

Tramarin R., Ambrosetti M., De Feo S., Griffo R., Maslowsky F., Diaco T., Riccio C., Carlon R., Castello A., Ferratini M., Schweiger C., Chieffo C., Ciglia C., Lapolla A., Pietropaolo F., Furgi G., Martin G., Semprini P., Avallone A., Bertoli D., Belardinelli R., Soffiantino F., Scrutinio D., Maxia P., Coco R., Giustarini C., Anniboletti P., Favretto G., Vaghi P., Calisi P., Chiavetta C., Guarracini L., Marcellini G., Iannopollo M., Borello G., Matta M., Peccerillo N., Boncompagni . F, Amici A., Feraco E., Pulitanò G., Tripodi E., Capomolla S., Golino P., Parrilli G., Di Patria A., Di Gioia C., Micieli D., Perrotta S., Rubino A., Aulitto V., Riccio G., Codec L., Coruzzi P., Violi E., Nardini M., Urbinati S., Dcruz S., Piepoli M., Fucili A., Cerulli M., Roberto B., Balestra G., Tuniz D., Gori P., Marini R., Morgera T., Di Mario F., Volterrani M., Galati A., Salustri A., Jesi A.P., Lacch A., Loperfido F., Corsiglia L., Pantaleo P., Gigli G., Marchesi D., Febo O., Cobelli F., Malinverni C., Jones N., Anzà C., Frizelli R., Gei P., Acquistapace F., Pedretti R., Carugo S., Malfatto G., Meloni C., Giordano A., Schizzarotto A., Zanettini R., Bosco R., Occhi G., Aglieri S., Caprioli G., Cuocina N., Lazzaroni L., Laurenzi A., Savonelli C., Veniani M., Corda G., Meinecke C., Castiglioni G., Ravizza P., Giani P., Robustelli F., Gullace G., Passoni F., Barelli M.V., Richichi I., Rossi A., Politi A., Persico M., Giannuzzi P., Mazzucco G., Bosimini E., Riva G., Massobrio N., Gondoni L., Aina F., Ingignoli B., Cal M.V., Costante A., Villella M., La Rosa C., Sannia L., Barbanto P., Rametta R., Albanese D., Circo A., Raciti R., Scarnato L., Dispensa F., La Spina L., Stuto A., Vasco C., Gibiino S., Gabriele M., Dispensieri C., Carini V., Provvidenza M., Scalzini A., Macchi C., Fattirolli F., Vannucci M., Iacopetti L., Cordoni M., Gabriele F., Santoni R., Pitscheider W., Bettini R., Mandorla S., Anniboletti F., Patriarchi F., Baroni P.L., Bordin F., Biondi P., Bellotto F., Zanocco A., Ponchia A., Mantovani E., Li Greci E., Celegon L., Baracchi S., Pizzolato G., Peroni L., Apolloni E., Mosele G., Guarniero M., Roncon L., VIGORITO, CARLO, Tramarin, R., Ambrosetti, M., De Feo, S., Griffo, R., Maslowsky, F., Diaco, T., Riccio, C., Carlon, R., Castello, A., Ferratini, M., Schweiger, C., Chieffo, C., Vigorito, Carlo, Ciglia, C., Lapolla, A., Pietropaolo, F., Furgi, G., Martin, G., Semprini, P., Avallone, A., Bertoli, D., Belardinelli, R., Soffiantino, F., Scrutinio, D., Maxia, P., Coco, R., Giustarini, C., Anniboletti, P., Favretto, G., Vaghi, P., Calisi, P., Chiavetta, C., Guarracini, L., Marcellini, G., Iannopollo, M., Borello, G., Matta, M., Peccerillo, N., Boncompagni., F, Amici, A., Feraco, E., Pulitanò, G., Tripodi, E., Capomolla, S., Golino, P., Parrilli, G., Di Patria, A., Di Gioia, C., Micieli, D., Perrotta, S., Rubino, A., Aulitto, V., Riccio, G., Codec, L., Coruzzi, P., Violi, E., Nardini, M., Urbinati, S., Dcruz, S., Piepoli, M., Fucili, A., Cerulli, M., Roberto, B., Balestra, G., Tuniz, D., Gori, P., Marini, R., Morgera, T., Di Mario, F., Volterrani, M., Galati, A., Salustri, A., Jesi, A. P., Lacch, A., Loperfido, F., Corsiglia, L., Pantaleo, P., Gigli, G., Marchesi, D., Febo, O., Cobelli, F., Malinverni, C., Jones, N., Anzà, C., Frizelli, R., Gei, P., Acquistapace, F., Pedretti, R., Carugo, S., Malfatto, G., Meloni, C., Giordano, A., Schizzarotto, A., Zanettini, R., Bosco, R., Occhi, G., Aglieri, S., Caprioli, G., Cuocina, N., Lazzaroni, L., Laurenzi, A., Savonelli, C., Veniani, M., Corda, G., Meinecke, C., Castiglioni, G., Ravizza, P., Giani, P., Robustelli, F., Gullace, G., Passoni, F., Barelli, M. V., Richichi, I., Rossi, A., Politi, A., Persico, M., Giannuzzi, P., Mazzucco, G., Bosimini, E., Riva, G., Massobrio, N., Gondoni, L., Aina, F., Ingignoli, B., Cal, M. V., Costante, A., Villella, M., La Rosa, C., Sannia, L., Barbanto, P., Rametta, R., Albanese, D., Circo, A., Raciti, R., Scarnato, L., Dispensa, F., La Spina, L., Stuto, A., Vasco, C., Gibiino, S., Gabriele, M., Dispensieri, C., Carini, V., Provvidenza, M., Scalzini, A., Macchi, C., Fattirolli, F., Vannucci, M., Iacopetti, L., Cordoni, M., Gabriele, F., Santoni, R., Pitscheider, W., Bettini, R., Mandorla, S., Anniboletti, F., Patriarchi, F., Baroni, P. L., Bordin, F., Biondi, P., Bellotto, F., Zanocco, A., Ponchia, A., Mantovani, E., Li Greci, E., Celegon, L., Baracchi, S., Pizzolato, G., Peroni, L., Apolloni, E., Mosele, G., Guarniero, M., and Roncon, L.

Subjects
Heart Failure, Male, Internet, Time Factors, Heart Diseases, Cardiologia Riabilitativa, Data Collection, Myocardial Infarction, Rehabilitation Centers, Factor IX, Prevenzione secondaria, Italy, Risk Factors, Health Care Surveys, Practice Guidelines as Topic, Humans, Female, Longitudinal Studies, Public Health, ISYDE 2008, Coronary Artery Bypass, Follow-Up Studies
Abstract

In this paper, the Italian Society of Cardiac Rehabilitation and Prevention (GICR) presents the third survey on the status of cardiac rehabilitation (CR) in Italy. The Italian SurveY on carDiac rEhabilitation 2008 (ISYDE 2008) is a multicenter, observational study aimed at identifying the number and characteristics of Italian CR facilities, both in terms of health operators and interventions. Clinical records of all patients consecutively discharged within the whole network--composed of up to 200 CR units--from January 28 to February 10, 2008 will also be reviewed for diagnosis of admission, comorbidities, rehabilitation programs, and drug therapy, in order to obtain a snapshot of current implementation strategies in daily clinical practice. The survey will adopt a web-based methodology for data provision and transmission. Preliminary results of the survey are expected in the late summer 2008.

Published
2008

48. Surgical strategy in the treatment of pancreatic neuroendocrine tumors

Author

Falconi, M., Bettini, R., Boninsegna, L., Stefano Crippa, Butturini, G., Pederzoli, P., Falconi, M., Bettini, R., Boninsegna, L., Crippa, S., Butturini, G., and Pederzoli, P.

Subjects
Neoplasm Invasivene, Cholecystectomy, Gastrinoma, Humans, Insulinoma, Intraoperative Period, Liver, Liver Neoplasms, Liver Transplantation, Multiple Endocrine Neoplasia Type 1, Neoplasm Invasiveness, Neoplasm Metastasis, Neuroendocrine Tumors, Pancreas, Pancreatic Neoplasms, Neoplasm Metastasi, Liver Neoplasm, Pancrea, Neuroendocrine Tumor, Human, Ultrasonography
Abstract

Endocrine pancreatic tumors are rare and their surgical treatment is often debated. This review analyzes the management and the different indications in functioning and non-functioning neoplasms. The choice among different procedures is described as well as the role of intra operative ultrasound. Moreover, the different patterns of tumor spread are considered (local, loco-regional and metastatic) along with the indications according to the main controversies relating to cytoreductive surgery, transplantation and multiple endocrine neoplasia type 1 patients.

Published
2006

Catalog

Books, media, physical & digital resources
See catalog results